Insider Selling: STERIS (NYSE:STE) VP Sells 5,036 Shares of Stock

November 21, 2025 by InsiderTrades.com

Key Points

STERIS VP Renato Tamaro sold 5,036 shares on Nov. 18 at an average price of $257.55 for about $1.30M, cutting his ownership by 46.93% to 5,695 shares.
Quarterly results beat estimates: Q3 EPS was $2.47 versus $2.38 expected and revenue was $1.46B versus $1.43B, and management set FY2026 guidance of $10.15–$10.30 EPS.
Dividend and valuation: The company declared a $0.63 quarterly dividend (1.0% yield, $2.52 annualized), trades at a ~39.6 P/E, and carries an average analyst price target of $273.50 ("Moderate Buy").

STERIS plc (NYSE:STE - Get Free Report) VP Renato Tamaro sold 5,036 shares of the firm's stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the sale, the vice president owned 5,695 shares of the company's stock, valued at $1,466,747.25. The trade was a 46.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

STERIS Price Performance

Shares of NYSE:STE opened at $258.36 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.53 and a current ratio of 2.22. The company has a market capitalization of $25.36 billion, a PE ratio of 39.57 and a beta of 1.02. The stock has a fifty day moving average of $246.64 and a 200-day moving average of $241.14. STERIS plc has a one year low of $200.98 and a one year high of $268.30.

STERIS (NYSE:STE - Get Free Report) last released its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share for the quarter, beating analysts' consensus estimates of $2.38 by $0.09. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. STERIS had a return on equity of 14.17% and a net margin of 11.61%.During the same quarter last year, the company posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, equities analysts anticipate that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Stockholders of record on Tuesday, November 18th will be paid a $0.63 dividend. The ex-dividend date of this dividend is Tuesday, November 18th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. STERIS's dividend payout ratio is 36.21%.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on STE shares. Wall Street Zen raised STERIS from a "buy" rating to a "strong-buy" rating in a research report on Sunday, September 14th. Morgan Stanley raised their price objective on shares of STERIS from $276.00 to $295.00 and gave the company an "overweight" rating in a research report on Friday, August 8th. Finally, Weiss Ratings restated a "buy (b)" rating on shares of STERIS in a report on Tuesday, October 14th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $273.50.

View Our Latest Stock Analysis on STE

Institutional Investors Weigh In On STERIS

Several hedge funds have recently made changes to their positions in the stock. Magnolia Capital Advisors LLC raised its stake in shares of STERIS by 1.2% in the third quarter. Magnolia Capital Advisors LLC now owns 3,588 shares of the medical equipment provider's stock valued at $888,000 after purchasing an additional 41 shares in the last quarter. Colonial Trust Co SC increased its holdings in STERIS by 0.3% in the 3rd quarter. Colonial Trust Co SC now owns 12,329 shares of the medical equipment provider's stock valued at $3,051,000 after buying an additional 42 shares during the period. Allworth Financial LP raised its stake in shares of STERIS by 7.3% in the 2nd quarter. Allworth Financial LP now owns 661 shares of the medical equipment provider's stock valued at $159,000 after buying an additional 45 shares in the last quarter. Geneos Wealth Management Inc. lifted its holdings in shares of STERIS by 34.9% during the 2nd quarter. Geneos Wealth Management Inc. now owns 174 shares of the medical equipment provider's stock worth $42,000 after acquiring an additional 45 shares during the period. Finally, Fifth Third Bancorp boosted its position in shares of STERIS by 1.6% during the 3rd quarter. Fifth Third Bancorp now owns 2,953 shares of the medical equipment provider's stock valued at $731,000 after acquiring an additional 46 shares in the last quarter. Institutional investors own 94.69% of the company's stock.

STERIS Company Profile

(Get Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.